Last news
Bakery China 2026 Concludes Successfully, Advancing Global Integration and Innovation in the Bakery Industry

Bakery China 2026 Concludes Successfully, Advancing Global Integration and Innovation in the Bakery Industry

SHANGHAI, June 1, 2026 /PRNewswire/ -- Bakery China 2026, the 28th edition of the exhibition, concluded successfully on May 23 at the National Exhibition and Convention Center (NECC) in Shanghai, reinforcing its role as a major global platform for...

KLN Receives High Recognition in ESG Performance, Achieves Highest AAA Rating in MSCI ESG and Wins HKQAA Hong Kong Green and Sustainability Contribution Awards 2026

KLN Receives High Recognition in ESG Performance, Achieves Highest AAA Rating in MSCI ESG and Wins HKQAA Hong Kong Green and Sustainability Contribution Awards 2026

HONG KONG, June 1, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce that its exceptional environmental, social and governance (ESG) performance has earned it an upgrade in MSCI ESG Rating to the...

Millennium Premier Hotel New York Times Square Reopens June 1 Following Comprehensive Renovation

Millennium Premier Hotel New York Times Square Reopens June 1 Following Comprehensive Renovation

Millennium Hotels and Resorts unveil a reimagined boutique experience in the heart of Manhattan, celebrating the reopening with an exclusive MyMillennium member offer. NEW YORK, June 1, 2026 /PRNewswire/ -- Millennium Hotels and Resorts (MHR), an...

Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II study in Heavily Pretreated mCRPC Patients at 2026 ASCO Annual Meeting

Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II study in Heavily Pretreated mCRPC Patients at 2026 ASCO Annual Meeting

HANGZHOU and SHANGHAI, China, June 1, 2026 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, today announced updated...

WePlay Korea's 4th Anniversary Celebration Kicks Off, Joining Hands with "Hello Panda-哈啰潘达" to Create Fu Bao Themed Space Decorations

WePlay Korea's 4th Anniversary Celebration Kicks Off, Joining Hands with "Hello Panda-哈啰潘达" to Create Fu Bao Themed Space Decorations

SEOUL, South Korea, June 1, 2026 /PRNewswire/ -- WePlay Korea, the global next-generation social entertainment platform, officially launched its 4th anniversary celebration today. To mark this milestone moment, WePlay has specially invited "Hello...

MMA INNOVATE Vietnam 2026 to Gather Leading Voices in Marketing and Technology

MMA INNOVATE Vietnam 2026 to Gather Leading Voices in Marketing and Technology

HO CHI MINH CITY, Vietnam, June 1, 2026 /PRNewswire/ -- With just over 10 days to go, MMA INNOVATE Vietnam 2026 is set to take place on June 10–11, bringing together one of the most anticipated gatherings for Vietnam's marketing, technology, and...

Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou

Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou

LIUZHOU, China, June 1, 2026 /PRNewswire/ -- On May 31, the 6th LiuGong (000528.SZ) Global Customer Day was held in Liuzhou, China. Mr. Su Zimeng, President of the China Construction Machinery Association, Mr. Song Zhiping, President of the China...

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications SEOUL, South Korea, June 1, 2026 /PRNewswire/ -- Hanmi Pharm. Co., Ltd. ("Hanmi") today announced that they have entered into a license agreement for the development,...

1 ... 8 9 10 11 12 13 14 15 16 ... 4651
menu
menu